Liposomal Cyclosporine A (L-CsA) via Inhalation to Treat Bronchiolitis Obliterans Syndrome: Novel Formulation and Drug-Specific Delivery System Improves Tolerability

Henig N.; Teichmann J.; Paulukat J.; Kappeler D.; Denk O.; Boerner G.

首页> 外文期刊>The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation >Liposomal Cyclosporine A (L-CsA) via Inhalation to Treat Bronchiolitis Obliterans Syndrome: Novel Formulation and Drug-Specific Delivery System Improves Tolerability

【24h】

Liposomal Cyclosporine A (L-CsA) via Inhalation to Treat Bronchiolitis Obliterans Syndrome: Novel Formulation and Drug-Specific Delivery System Improves Tolerability

机译：脂质体环孢菌素A（L-CSA）通过吸入治疗支气管炎梗阻综合征：新型配方和药物特异性递送系统可提高耐受性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation》 |2019年第4suppla期|共2页
作者
Henig N.; Teichmann J.; Paulukat J.; Kappeler D.; Denk O.; Boerner G.;
展开▼
作者单位

Breath Therapeut Menlo Pk CA USA;

Breath Therapeut Menlo Pk CA USA;

Breath Therapeut Menlo Pk CA USA;

Breath Therapeut Menlo Pk CA USA;

Breath Therapeut Menlo Pk CA USA;

Breath Therapeut Menlo Pk CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类器官移植术;
关键词

相似文献

外文文献
中文文献
专利

1. Liposomal Cyclosporine A (L-CsA) via Inhalation to Treat Bronchiolitis Obliterans Syndrome: Novel Formulation and Drug-Specific Delivery System Improves Tolerability [J] . Henig N., Teichmann J., Paulukat J., The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation . 2019,第4Suppla期

机译：脂质体环孢菌素A（L-CSA）通过吸入治疗支气管炎梗阻综合征：新型配方和药物特异性递送系统可提高耐受性
2. TOWARDS PREDICTION OF THE PHARMACOKINETICS OF INHALED NANOMEDICINE FROM PHYSIOLOGICAL CELL MODELS: A CASE STUDY WITH LIPOSOMAL CICLOSPORIN A (L-CSA) USING THE VITROCELL CLOUD SYSTEM [J] . Orak Sezer, Rothen-Rutishauser Barbara, Jud Corinne, Journal of aerosol medicine and pulmonary drug delivery . 2019,第3期

机译：从生理细胞模型预测吸入纳米胺的药代动力学：使用vitrocell云系统与脂质体ciclosporina（l-csa）的案例研究
3. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: Results of a prospective, randomized international trial in lung transplantation [J] . TreedeH., GlanvilleA.R., KlepetkoW., The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation . 2012,第8期

机译：他克莫司和环孢菌素对闭塞性细支气管炎综合征发展的风险有不同的影响：一项前瞻性随机国际肺移植试验的结果
4. Characterization of Nebulized Liposomes: Preliminary Studies for Inhalative Application of a Liposomal Drug Delivery System for Vasoactive Intestinal Peptide [C] . Brigitte Stark, Fritz Andreae, Ruth Prassl Controlled Release Society Annual Meeting and Exposition . 2007

机译：雾化脂质体的表征：血管活性肠肽的脂质体给药系统的吸入应用的初步研究
5. Formulation of Controlled Liposomal Drug Delivery System [D] . Lee, Young. 2017

机译：受控脂质体药物递送系统的制定
6. A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation [O] . Aldo Iacono, Marniker Wijesinha, Keshava Rajagopal, 2019

机译：吸入脂质体环孢素在肺移植后闭塞性细支气管炎综合征中的随机单中心试验
7. A Single Center, Randomized, Open-Label, Controlled Pilot Study to Demonstrate Efficacy and Safety of the Addition of Inhaled Liposomal Cyclosporine (L-CsA) Therapy versus Standard Therapy Alone in the Treatment of Bronchiolitis Obliterans Syndrome (BOS) Following Lung Transplantation [O] . A. Iacono, M. Terrin, K. Rajakopal, 2016

机译：单一中心，随机开放标签，受控试验研究，以证明添加吸入脂质体环孢子（L-CSA）治疗的疗效和安全性与标准治疗单独治疗肺癌后肺癌患者综合征综合征（BOS）

Liposomal Cyclosporine A (L-CsA) via Inhalation to Treat Bronchiolitis Obliterans Syndrome: Novel Formulation and Drug-Specific Delivery System Improves Tolerability

著录项

相似文献

相关主题

期刊订阅